The Obama administration’s decision to bring criminal charges against members of the Chinese military is already showing signs of straining the U.S. relationship with China.
Shortly after the Justice Department accused five Chinese officers of hacking U.S. companies, China announced that it is withdrawing from a joint cybersecurity working group. The U.S. and China launched the working group last year to try to reach agreements over the use of cyber espionage.
Qin Gang, a spokesman for the Chinese government, said China will announce more retaliations “as the situation evolves.”
According to the indictments, the five men were members of a hacking group that stole trade secrets from major U.S. companies including Westinghouse, United States Steel, and Alcoa.
But the Chinese spokesman claimed the charges were “based on deliberately fabricated facts.” He also pointed to the Edward Snowden leaks as evidence that the U.S. is hypocritical when it condemns others for spying.
“China is a victim of severe U.S. cybertheft, wiretapping, and surveillance activities,” he claimed.
When Attorney General Eric Holder announced the indictments Monday, he emphasized that China’s behavior is fundamentally different than spying by the National Security Agency. The U.S. may spy on other countries, but it does not steal secrets to give its own companies an economic edge, he argued.
Adam Segal, a senior fellow with the Council on Foreign Relations, said it’s not likely that China will try to bring criminal charges against NSA officials or other members of the U.S. government. But he said he expects China to take other steps against the U.S. in the coming days.
Segal explained that China doesn’t see an important distinction between spying to protect national security and spying to help domestic companies.
“There’s not such a clear line between the public and private sector in China,” he said. “Their conception of economic power and national power doesn’t really see this distinction.”
- 1 The Story of 2016: Republicans Feeling “Betrayed” by Their Leaders
- 2 The 14 House Primaries to Watch Tuesday
- 3 After Trump, GOP Foreign Policy Faces an Uncertain Future
- 4 Climate Stances Put Pressure on Major Trade Groups
- 5 Smart Ideas: Oil Pipelines vs. Oil Trains, and the Next Generation of Biological Threats
What We're Following See More »
Sigmar Gabriel, the German economic minister, said there's no chance of the Transatlantic Trade and Investment Partnership being agreed upon before the U.S. elections this fall. Gabriel said the United States "had effectively ended talks" on the free trade deal with the European Union "because Washington had not wanted to compromise with its European counterparts."
In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.
“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”
"Humanity’s impact on the Earth is now so profound that a new geological epoch—the Anthropocene—needs to be declared," according to a panel of scientists. "The new epoch should begin about 1950, the experts said, and was likely to be defined by the radioactive elements dispersed across the planet by nuclear bomb tests, although an array of other signals, including plastic pollution, soot from power stations, concrete, and even the bones left by the global proliferation of the domestic chicken."
The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.